✦ LIBER ✦

PMH51 COST-EFFECTIVENESS EVALUATION OF LONG-ACTING RISPERIDONE

✍ Scribed by J Locklear; N Edwards; MF Rupnow; R Diamond

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH23 COST-EFFECTIVENESS EVALUATION OF L

✍ N Edwards; M Rupnow; CL Pashos; MF Botteman; J Locklear; R Diamond 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH21 THE COST-EFFECTIVENESS OF RISPERID

✍ J Damen; BMS Heeg; M Lothgren; BA Van Hout 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH21 COST-EFFECTIVENESS-ANALYSIS OF RIS

✍ J Skoupá; V Cerna; T Doležl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMH36 Cost-Effectiveness of Depot Flupen

✍ S. Frey; T. Stargardt; R. Linder; G. Juckel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB